U.S. DoS Cable: Brazil’s National Health Council Recommends Compulsory Licensing – August 12, 2005

  R 122031Z AUG 05 – August 12, 2005FM AMEMBASSY BRASILIATO SECSTATE WASHDC 2501SUBJECT: Brazil’s National Health Council Recommends Compulsory Licensing of Antiretrovirals 1. SENSITIVE BUT UNCLASSIFIED 2. (SBU) Summary.  Adding to the tension surrounding negotiations between the ministry of… Continue Reading

U.S. DoS Cable: U.S. PHARMA FIRMS THREATENED WITH LICENSING (Brazil)

R 031944Z JUN 05 – June 3, 2005FROM: American Embassy BrasiliaTO: Secretary of State, Washington, D.C.SUBJECT: AMBASSADOR MEETS WITH U.S. PHARMACEUTICAL FIRMS THREATENED WITH LICENSING 1. (SBU) Summary.  On May 24 and 25, U.S. pharmaceutical companies Gilead Sciences, Abbott Laboratories,… Continue Reading

CPTech Statement on WTO Deal on Exports of Medicines

Original page: http://www.cptech.org/ip/wto/p6/cptech08302003.html CPTech Statement on WTO Deal on Exports of Medicines August 30, 2003 “Today’s decision on the implementation of paragraph 6 of the Doha Declaration on TRIPS and Public Health puts the WTO into unchartered waters. The WTO… Continue Reading

USTR Zoellick Letter to TACD IP Group Regarding WTO Compulsory Licensing Mechanism

Original page: http://www.cptech.org/ip/wto/p6/zoellick02102003.doc RECEIVED 24 FEB 2003 Executive Office of the President The United States Trade Representative Washington, DC 20508 February 10, 2003 Mr. James Love Co-Chair TACD IP-workinggroup TACD Secretariat 24 Highbury Crescent UK-London N5 1RXDear Mr. Love, Thank… Continue Reading